• MolecularMatch Works to Commercialize Clinical-Trial-Matching Software

    Apr 28, 2016, 11:00 by Michael Croft
    Clinical Informatics News | MolecularMatch runs a free online search engine for clinical trials, with a registry that is beginning to rival clinicaltrials.gov. Now it wants to arm pathology labs with the same context-aware search engine to help interpret the results of molecular tests.
    Full story
  • Apple’s CareKit and the AI future of medical care

    Apr 28, 2016, 10:36 by Michael Croft
    Computerworld |  Apple's focus on personal health through connected devices ramps up a little more today with the release of the first four third party apps to integrate its newly announced open source CareKit technologies.
    Full story
  • Here Are Three Ways To Prevent Tragic Battles Between The FDA And Patients

    Apr 28, 2016, 09:09 by Michael Croft
    Forbes |  Last night, a panel of advisors to the Food and Drug Administration voted 7 to 3, with 3 abstentions, that the agency should not approve eteplirsen, a drug for a Duchenne muscular dystrophy, a rare, deadly, muscle-destroying disease, developed by Sarepta, a Cambridge, Mass.-based biotechnology firm. (On another vote, which [...]
    Full story
  • Certara Launches New E-learning Platform for Biosimulation Education

    Apr 28, 2016, 08:19 by Michael Croft
    PRINCETON, NJ - Apr 28, 2016 - Certara®, the global biosimulation technology-enabled drug development company, today launched an e-learning platform through Certara University to satisfy the increased need for education in the burgeoning field of biosimulation or model-based drug development
    Full story
  • Oasmia Pharmaceutical Announces Positive Overall Survival Results from Phase III Study of Paclical/Apealea for Treatment of Ovarian Cancer

    Apr 27, 2016, 18:22 by Michael Croft
    NEW YORK, NY, UNITED STATES - Apr 27, 2016 - April 27, 2016 -- Oasmia Pharmaceutical AB (OASM), a developer of a new generation of drugs within human and veterinary oncology, today announced positive overall survival results for Paclical/Apealea in the Phase III study that included a total of 789 patients with epithelial ovarian cancer
    Full story
  • Montrium Releases eTMF Navigator to Provide Greater Business Intelligence in Clinical Trials

    Apr 27, 2016, 16:46 by Michael Croft
    MONTREAL, QC, CANADA - Apr 28, 2016 - Montrium, clinical trial technology specialists, and electronic content management software providers, today, announced the commercial release of the eTMF Navigator, an interactive intelligence dashboard integrated into eTMF Connect
    Full story
  • April Clinical News and Product Briefs

    Apr 27, 2016, 10:00 by Michael Croft
    Clinical Informatics News | The latest announcements and product releases from around the industry, including a major data sharing initiative for BRCA testing, and LifeMap Solutions' tailored service for smartphone-enabled research studies.
    Full story
  • Queen’s University Belfast and Domainex Win Late-Stage Award to Progress Novel Lung Cancer Drug Candidate into the Clinic

    Apr 26, 2016, 10:35 by Michael Croft
    BELFAST AND CAMBRIDGE, UK - Apr 26, 2016 - Queen’s University Belfast and Domainex Ltd. announced today that they have secured a late-stage award from the Wellcome Trust Seeding Drug Discovery scheme to advance therapeutic candidate molecules into clinical evaluation for treatment of non-small cell lung carcinoma (NSCLC)
    Full story
  • Augmedix 'Rehumanizing’ Doctor Patient Relations Using Google Glass

    Apr 26, 2016, 09:54 by Michael Croft
    TechCrunch |  Augmedix, creator of a Google Glass platform for doctors to interact with medical data in real time, raised an additional $17 million this week.
    Full story
  • Sequencing Predicts Cancer Vaccine's Outcomes

    Apr 25, 2016, 15:45 by Michael Croft
    Clinical Informatics News | A new study by UCLA researchers demonstrates the use of next generation sequencing to predict survival of brain cancer patients treated with a cancer vaccine. The vaccine, an autologous dendritic cell therapy called DCVax-L, is under development by Northwest Biotherapeutics Inc., of Bethesda, Md., for glioblastoma multiforme (GBM). It is designed to activate the adaptive immune system, including T lymphocytes (T cells).
    Full story
  • FDA and WHO Warn About Clinical Trials Run by an Indian Company

    Apr 25, 2016, 15:44 by Michael Croft
    STAT |  An investigation into Semler Research Center in Bangalore has uncovered "manipulation of at least five studies over an extended period of time."
    Full story
  • Human Longevity, AstraZeneca DNA Sample Deal from Clinical Trials

    Apr 22, 2016, 13:55 by Michael Croft
    Clinical Informatics News  Human Longevity, Inc. (HLI), has announced a 10-year deal with AstraZeneca to sequence and analyze up to 500,000 DNA samples from AstraZeneca clinical trials. The genomic insights from the collaboration will be added to the HLI Knowledgebase.
    Full story
  • Clincierge’s White Glove Style Boosts Patient Retention

    Apr 21, 2016, 10:55 by Michael Croft
    Clinical Informatics News | 2016 Best Practices Awards | Retaining patients in clinical trials is notoriously difficult, and if those trials are for rare diseases, retention is even tougher. That’s where Clincierge comes in. Their efforts to improve patient retention with patient concierge services grabbed the attention of the judges of the 2016 Clinical Informatics News Best Practices Awards.
    Full story
  • Bracket Announces New Patient Engagement Tools for eCOA and RTSM Products

    Apr 21, 2016, 10:13 by Michael Croft
    WAYNE, PA, UNITED STATES - Apr 20, 2016 - A Bracket, a leading clinical trial specialty services provider, announced platform updates to Bracket eCOATM and Bracket RTSMTM to include native support for SMS messaging with patients and other stakeholders in clinical research programs
    Full story
  • Bluebird Bio Gene Therapy Shows Early Promise in Fatal Childhood Brain Disease

    Apr 20, 2016, 10:17 by Michael Croft
    TheStreet |  Bluebird bio has released interim data from its Phase 2/3 trial of its gene therapy Lenti-D, which suggests the approach may be comparably effective to bone marrow transplant for children with the rare disease cerebral adrenoleukodystrophy.
    Full story
  • Post-Authorization Study Develops Into Crucial Part of Drug Development Design

    Apr 20, 2016, 09:23 by Michael Croft
    BERLIN, GERMANY - Apr 20, 2016 - Post-authorization safety studies (PASS) are becoming an integral part of the medicines development. Planning the design of PASS in the early phases of a clinical trial will translate into significant time- and cost-efficiency of pre-approval research
    Full story
  • Bioclinica, ArisGlobal Announce Partnership

    Apr 19, 2016, 11:30 by Michael Croft
    Clinical Informatics News Brief | Bioclinica has chosen ArisGlobal’s Safety Cloud as the preferred safety platform for its pharmacovigilance services; Bioclinica will become the preferred partner for ArisGlobal in business process consulting and change management as sponsors implement or upgrade ARISg.
    Full story
  • ICGCmed launches today will link genomics to clinical information and health

    Apr 19, 2016, 09:35 by Michael Croft
    MedicalXpress |  The International Cancer Genome Consortium (ICGC) announced plans to launch the International Cancer Genome Consortium for Medicine (ICGCmed), a new phase in the Consortium's evolution that will link genomics to clinical information and health. By linking the ICGC data with clinical information, ICGCmed aims to accelerate the movement of this information into the clinic to guide prevention, early detection, diagnosis and prognosis.
    Full story
  • Cleveland Clinic American Well to provide CVS MinuteClinic customers with access to video visits

    Apr 14, 2016, 12:42 by Michael Croft
    MobiHealthNews |  Cleveland Clinic providers will now offer online and mobile video visits to CVS Minute Clinic customers in Ohio. The partnership is powered by American Well's video visits offering. American Well previously partnered with CVS and Cleveland Clinic in separate deals.
    Full story
  • Cleveland Clinic Partnership with CVS MinuteClinics is an Important Step for Telehealth

    Apr 14, 2016, 09:56 by Michael Croft
    Fast Company |  The major Ohio hospital has partnered with CVS's MinuteClinics and American Well to offer telehealth consults through walk-in clinics.
    Full story
  • «
  • 251
  • 252
  • 253 (current)
  • 254
  • 255
  • 256
  • 257
  • 258
  • 259
  • 260
  • »